ClinConnect ClinConnect Logo
Search / Trial NCT05237869

Blood Flow Restriction & Tennis Elbow Rehab

Launched by JULIE NUELLE · Feb 2, 2022

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying a new approach to help people with tennis elbow, also known as lateral epicondylitis. This condition causes pain on the outside of the elbow and often affects those who use their arms a lot, leading to weakness and discomfort. The trial aims to find out if a method called blood flow restriction therapy can help reduce pain quickly and improve recovery for patients. Researchers want to learn more about effective treatments since current options aren’t always helpful.

To participate in this study, you need to be between 18 and 65 years old and have a confirmed diagnosis of tennis elbow from an orthopedic surgeon. You should also be able to read and write in English and give your consent to participate. Unfortunately, if you're over 65, have certain medical conditions, or have had specific treatments in the past year, you won’t be eligible for this trial. If you qualify, you can expect to take part in a program designed to help your elbow heal, and you'll be closely monitored throughout the process. This study is currently looking for participants, so if you think you might fit the criteria, it could be a good opportunity to help improve treatments for tennis elbow.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Ages 18-65 years of age
  • 2. Diagnosis of lateral epicondylitis confirmed by the treating orthopaedic surgeon and ultrasound
  • 3. Must be able to read and write in English
  • 4. Able to provide own written consent
  • Exclusion Criteria:
  • 1. Patients over 65 years of age
  • 2. Contralateral upper extremity involvement resulting in less than normal range of motion, muscle strength or daily pain greater than 1/10
  • 3. History of prior injection for treatment of lateral epicondylitis
  • 4. Pregnancy
  • 5. Recent history of deep venous thrombosis (within the past 12 months)
  • 6. Active treatment with anticoagulants
  • 7. History of upper quadrant lymph node dissection
  • 8. History of endothelial dysfunction
  • 9. Patient history of easy bruising
  • 10. Active infection in the injured arm
  • 11. Cancer
  • 12. Uncontrolled peripheral vascular disease
  • 13. Uncontrolled diabetes mellitus

About Julie Nuelle

Julie Nuelle is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes. With a focus on innovative therapies and a collaborative approach, Julie Nuelle facilitates the design, execution, and management of clinical trials across various therapeutic areas. Leveraging a robust network of clinical sites and experienced professionals, the organization prioritizes ethical standards, regulatory compliance, and patient safety, ensuring that each study contributes valuable insights to the medical community. Through strategic partnerships and a patient-centered ethos, Julie Nuelle aims to drive meaningful advancements in healthcare.

Locations

Columbia, Missouri, United States

Columbia, Missouri, United States

Patients applied

0 patients applied

Trial Officials

Julia Nuelle, MD

Principal Investigator

University of Missouri Department of Orthopaedic Surgery

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials